OSR Health (OSRHW) Tax Provisions (2023 - 2026)

OSR Health (OSRHW) posted Tax Provisions of -$452314.0 for Q1 2026, up 15.43% sequentially from -$534868.0 in Q4 2025.

OSR Health (OSRHW) Tax Provisions (2023 - 2026) Analysis & Trends

OSR Health has reported Tax Provisions for 4 years, with the latest figure at -$452314.0 in Q1 2026.

Quarterly Tax Provisions changed N/A year-over-year to -$452314.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 million (changed N/A YoY) and the FY2025 annual result came in at -$1.8 million, down 17.01% from the prior year.
Tax Provisions climbed to -$452314.0 in Q1 2026 per OSRHW's latest filing, from -$534868.0 in the prior quarter.
Over five years, Tax Provisions peaked at $228565.0 in Q2 2023 and troughed at -$1.3 million in Q3 2025.
A 4-year average of -$300462.8 and a median of -$139560.0 in 2024 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 18.71% in 2025, down 827.88% in 2025.
Over 4 years, Tax Provisions stood at $153040.0 in 2023, then sank by 394.42% to -$450585.0 in 2024, then dropped by 18.71% to -$534868.0 in 2025, then increased by 15.43% to -$452314.0 in 2026.
According to Business Quant data, Tax Provisions over the past three periods registered -$452314.0, -$534868.0, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.12 Bn	131.27 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.30 Bn	77.31 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	62.84 Bn	57.66 Bn	1.37 Bn	59.00 Mn
4	Moderna	55.67 Bn	50.53 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.43 Bn	36.33 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.70 Bn	28.39 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	27.47 Bn	9.08 Bn	668.28 Mn	-90.33 Mn
8	Royalty Pharma	27.16 Bn	26.33 Bn	-	-
9	Insmed	27.03 Bn	25.87 Bn	358.27 Mn	1.90 Mn
10	OSR Health	1.40 Mn	20.39 Mn	86,605.00	-439,503.00

Download Data